Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
KENYA – Merck Foundation has conducted their Annual Kenya Alumni Summit in Nairobi to discuss their programs with their partners and beneficiaries to transform patient care landscape in Kenya through…
Read More
SWITZERLAND- Fiona Marshall, a Merck executive, has been named president of the Novartis Institutes for Biomedical Research (NIBR)to succeed Jay Bradner. James (Jay) E. Bradner, M.D., will step down from…
Read More
INDIA- Merck has established a Healthcare R&D Excellence Center facility that will help develop future medical treatments for individuals with unmet medical requirements all around the world. The R&D Excellence…
Read More
USA- Merck has released its 2021/2022 Environmental, Social, and Governance (ESG) Growth Report, which highlights the company’s performance and progress in four ESG emphasis areas The ESG areas include; Access…
Read More
SOUTH AFRICA – South African Startupbootcamp AfriTech (SBC) has partnered with Moroccan consulting firm Southbridge A&I and its Canadian partner Salient Advisory to launch a US$7 million innovator support program…
Read More
USA – A report in The Wall Street Journal has said Merck & Co. is considering a buyout of Seagen, a pioneer in the use of antibody-drug conjugates (ADCs) to…
Read More
AFRICA – Leading science and technology company Merck has announced the upcoming launch of the Africa Cancer Care program to enhance colorectal cancer diagnosis across Africa and new thyroid awareness…
Read More
AFRICA – Africa Reproductive Care society (ARCS) has championed for fertility care and women’s healthcare capacity building in partnership with Merck Foundation. The Merck Foundation, the philanthropic arm of Merck…
Read More
USA – According to a news release from, Merck, the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with advanced endometrial carcinoma that is…
Read More
USA – Merck has released specific data for Keytruda in early-stage lung cancer, indicating an advantage over Roche’s first-to-market Tecentriq. Postsurgery use of Keytruda reduced the risk of disease recurrence…
Read More